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Annual rupture risk of abdominal aortic aneurysm
enlargement without detectable endoleak after
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Aortic Aneurysm Repair (EUROSTAR), Utrecht and Eindhoven, The Netherlands
Objectives:Whether abdominal aortic aneurysm (AAA) enlargement after endovascular aneurysm repair (EVAR), without
an identifiable endoleak, is a risk factor for AAA rupture remains controversial. To our knowledge, studies including large
patient numbers investigating this topic have not been done. Therefore, a considerable number of conversions to open
AAA repair have been performed in this patient group. This study evaluated AAA rupture risk in patients without
detectable endoleaks but with AAA enlargement after EVAR treatment.
Methods: Baseline characteristics and follow-up data were collected prospectively by case record forms. Follow-up visits
were scheduled at 1, 3, 6, 12, 18, and 24 months, and annually thereafter. The follow-up assessment included clinical
examination and imaging studies. Patients were divided into three groups according to the degree of shrinkage or
enlargement of the aneurysm. Group A included patients with>8mm aneurysm shrinkage, group B consisted of patients
with <8 mm shrinkage to <8 mm enlargement, and group C patients had an aneurysm enlargement of >8 mm.
Results: The basis for this analysis was 6337 patients who were enrolled prospectively in the European Collaborators on
Stent-Graft Techniques for Aortic AneurysmRepair (EUROSTAR) database between 1996 and 2006. Group A included
691 patients; group B, 5307 patients; and group C, 339 patients. Ruptures occurred in 3 patients in group A, in 14
patients in group B, and in 9 patients in group C. The annual rate of rupture in group C was <1% in the first 4 years but
accelerated to 7.5% up to 13.6% in the years thereafter. The mortality rate of elective conversion to open AAA repair was
6.0%.
Conclusions:The risk of rupture in patients with an AAA enlargement of 8mm after EVAR, without detectable endoleaks,
is <1% in the first 4 years. No ruptures were seen in patients with AAA enlargement without detectable endoleaks who
were not treated with Vanguard stent grafts (Boston Scientific Corp, Natick,Mass) and had AAA diameters<70mm. For
this group, conversion to open repair might not be mandatory, and regular follow-up can be advised instead. After 4 years
of follow-up, this study observed an increased annual rupture risk, which might indicate the need for conversion;
however, groups are small, and follow-up bias could play a role. ( J Vasc Surg 2011;54:1614-22.)
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iTreatment of abdominal aortic aneurysms (AAAs) aims
at aneurysm exclusion, depressurization of the aneurysm
sac, and thereby, prevention of aneurysm rupture. In the
last decade, AAA treatment underwent a shift from open
AAA repair to endovascular aneurysm repair (EVAR).1
Endovascular repair of AAA disease is associated with a
significantly lower operative mortality rate than open re-
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1614air.2,3 However, exclusion of the AAA is not always defin-
tive, and a certain risk of AAA rupture after EVAR re-
ains.4-8
Rupture rates from different cohorts have varied be-
ween 0.5% and 1.2% per year after EVAR.3,9-15 The re-
orted mortality rate of a ruptured AAA after EVAR is 20%
o 38%.4 Confirmed risk factors for post-EVAR AAA rup-
ure include advanced age, large initial AAA diameter, graft
igration, or the presence of type I or III endoleaks.4,7,8,16
Although one tends to think of AAA enlargement after
VAR, without an identifiable endoleak, as a risk factor for
AA rupture, this relation has not been unequivocally
emonstrated.4,7,17 A recent guideline of the Society for
ascular Surgery (SVS) states, “On occasion, explantation
nd conversion may be required when no clear cause can be
etected and endoleak, as a cause of sac expansion, cannot
e excluded.”18 Also the guideline of the European Society
f Vascular Surgery (ESVS) states, “an enlarging abdomi-
al aortic aneurysm after endovascular abdominal aortic
epair without evidence of an endoleak and with an increase
n diameter  10 mm should usually be repaired surgically
r with a new stent graft.”19 Moreover, a previous consen-
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Volume 54, Number 6 Koole et al 1615sus conference suggested, “An enlarging aneurysm after
EVAR mandates surgical or interventional treatment.”20
As a consequence of these recommendations, a consider-
able number of conversions to open AAA repair have been
performed.
The purpose of this study was to assess the risk of
rupture after EVAR in patients with AAA enlargement but
without detectable endoleaks. This condition is also known
as endotension, a term that was introduced in 1999.21
Perioperativemortality of conversion to open AAA repair in
this patient category was also assessed. Finally, we ad-
dressed whether open conversion or a conservative ap-
proach with increased surveillance should be the preferred
management policy.
METHODS
Study population and organization of the reg-
istry. An account of the organization of the European
Collaborators on Stent-Graft Techniques for Aortic An-
eurysm Repair (EUROSTAR) Registry has been pub-
lished.10,16,22,23 Briefly, preoperative patient characteris-
tics, operative details, and follow-up data were initially
collected prospectively by means of case record forms on
paper, and after 2002 by using an on-line format (KIKA-
Medical, Nancy, France). Follow-up visits, according to the
protocol, were scheduled at 1, 3, 6, 12, 18, and 24months,
and annually thereafter. Findings of the clinical examina-
tion and imaging studies at the follow-up assessments were
recorded and data returned at standard times to the Data
Registry Center (Eindhoven, The Netherlands) for analy-
sis. Inclusion criteria were elective treatment for AAA dis-
ease and suitable vascular anatomy for implantation of a
Fig 1. Flow chart shows the study cohort inclusion. CT
rators on Stent-Graft Techniques for Aortic Aneurysm Rstent graft.23 oData of 6337 patients who were enrolled prospectively
n the EUROSTAR database between 1996 and 2006
onstituted the basis for this analysis. The study excluded
atients without follow-up and those without AAA diame-
er measurements after EVAR. Additional exclusion criteria
ere imagingmodalities other than computed tomography
CT), ultrasound (US) scans, or magnetic resonance imag-
ng (MRI). Patients with reported endoleaks were also
xcluded (Fig 1).
Aneurysm growth was determined by an increase in
neurysm diameter measured at its largest section, from
uter wall to outer wall across the minor diameter, on the
xial CT, US image, or MRI section. Aneurysm enlarge-
ent was defined as a diameter increase of 8 mm relative
o the preoperative diameter measurements on the in-
luded image.7,24-26 The maximum recorded aneurysm
iameter during follow-up was used for this analysis. Three
roups categorized by aneurysm enlargement, without de-
ectable endoleaks, were created and stratified as follows:
roup A represented patients with 8 mm aneurysm
hrinkage, group B consisted of patients with 8 mm
hrinkage to 8 mm enlargement, and group C had an
neurysm enlargement of 8 mm.
Statistical analysis. Results are reported as mean and
tandard deviation for continuous data and as percentage
or discrete data. We tested by univariate analysis whether
ignificant differences in baseline characteristics, operative
omplications, or brand of used device were present among
he defined study groups. Differences among the study
roups were analyzed with 2 tests for discrete variables and
nalysis of variance tests for continuous variables. Cumula-
ive rates of freedom from aneurysm rupture, conversion to
puted tomography; EUROSTAR, European Collabo-
; MRI, magnetic resonance imaging; US, ultrasound., Compen repair, and aneurysm-related deaths after EVAR were
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December 20111616 Koole et alassessed with survival table analysis, and rates with 10%
standard error were excluded from the analysis. Significant
differences among the defined study groups were analyzed
with log-rank testing. Variables with a significant correla-
tion with an adverse outcome event in the univariate anal-
ysis were entered in a multivariable Cox analysis to investi-
gate independent associations. All tests were two-sided,
with P  .05 considered statistically significant. Statistical
analyses were performed with SPSS 15.0 software (SPSS,
Chicago, Ill).
RESULTS
The study included 6337 patients, comprising 5948
men (93.9%) and 389 women (6.1%), who were a mean age
of 71.2 years (range, 36-100 years). Mean aneurysm diam-
eter was 57.2 mm (range, 26-172 mm). Group A included
691 patients, group B included 5307 patients, and group C
included 339 patients. Details of patient variables are sum-
marized in Table I. Group A had significantly more women
(2.3%) than group B; however, this was not the case when
group A was compared with group C. The preoperative
aneurysm diameter was significantly smaller in the group
with AAA enlargement compared with groups A and B.
Furthermore, group C had the smallest mean aortic neck
diameter, but the difference among the groups was not
significant (P  .063). The mean infrarenal aortic neck
length was 27.7 mm for group A, 27.5 mm for group B,
and 29.8 mm in patients with an AAA enlargement (P 
.005).
Mean duration of follow-up was 24.6 months (range,
Table I. Demographic data of patients undergoing endov
Variable
Group Aa Group B
No. % Mean (SD) No. % M
Age, years 691 70.6 (8.0) 5307 71
Male sex 634 91.8 4995 94.1
ASA class 2 361 53.2 2600 49.5
Diabetes 88 13.3 641 12.5
Cardiac history 405 58.6 3234 60.9
Renal insufficiency 149 21.6 1129 21.3
Pulmonary symptoms 277 42.0 2095 41.1
Hypertension 425 63.9 3321 64.5
Hypercholesterolemia 64 10.1 745 14.8
Current smoker 186 28.3 1276 24.9
Aneurysm diameter,
mm 691 61.6 (13.4) 5307 57
Infrarenal aortic neck
Diameter, mm 645 23.5 (3.3) 5132 23
Length, mm 652 27.7 (12.8) 5058 27
Aneurysmatic CIAs 59 8.5 503 9.5
AAA, Abdominal aortic aneurysm; ASA, American Society of Anesthesiolo
aAneurysm shrinkage 8 mm.
bAneurysm shrinkage 8 mm to enlargement 8 mm.
cAneurysm enlargement 8 mm.
dOverall P value was given to prevent multiple testing.
eFor continuous variables, Bonferroni post hoc analyses were performed to
between group A vs B, B vs C, and A vs C were performed with 2 tests con
Bonferroni’s correction method. Missing data on comorbidity ranged from1-120 months) for the entire study cohort. The mean muration of follow-up was 26.4 months for group A, 25.8
onths for group B, and 36.6 months for group C.
ollow-up was significantly longer for patients with an AAA
nlargement after EVAR compared with groups A and B
P  .001).
A total of 26 ruptures occurred in the entire study
ohort. The median time to rupture was 48 months. Free-
om from rupture in the entire study cohort was 95.9% at 7
ears. Ruptures occurred in 3 patients (0.4%) in group A, in
4 (0.32%) in group B, and in 9 (2.6%) in group C.
reedom from rupture at 7 years was 96.3% in group A,
8.9% in group B, and 79.5% in group C (P .001, Fig 2).
Univariate analysis for increased rupture risk was per-
ormed for baseline characteristics with significant differ-
nces between study groups, type of stent graft, and intra-
perative or postoperative complications (Table II).
ultivariable analysis indicated enlargement of the aneu-
ysm, initial diameter of the aneurysm, length of the infra-
enal aortic neck, and the Vanguard stent graft (Boston
cientific Corp, Natick, Mass) were independent factors for
n increased rupture risk (Table III).
Although group C had significantly higher rupture
ates at 7 years, the mean annual rupture risk was 1.1%. The
nnual rate of rupture in group C was 1% in the first 4
ears, but accelerated to 7.5% up to 13.6% in the years
hereafter (Table IV). The mean AAA diameter at the last
ollow-up in group C between the nonruptured and rup-
ured AAAs was 60.1 vs 74.2 mm (P .021). Many of the
uptured AAAs had a diameter of 70 mm (Table V).
roup C had 116 patients with an AAA diameter of 70
ar aneurysm repair, stratified by postoperative expansion
Group Cc
Pd
Post hoc Bonferroni Pe
SD) No. % Mean (SD)
Group
A vs B
Group
B vs C
Group
A vs C
.7) 339 70.4 (8.0) .021 .097 .154 1.000
319 94.1 .050 .045 1.000 .534
164 49.4 .198 .219 1.000 .780
38 11.8 .761 1.000 1.000 1.000
212 62.5 .395 .717 1.000 .681
81 23.9 .521 1.000 .762 1.000
121 38.1 .489 1.000 .831 .729
209 64.9 .941 1.000 1.000 1.000
45 14.1 .006 .003 1.000 .064
82 25.5 .168 .177 1.000 1.000
0.7) 339 51.4 (14.9) .001 .001 .001 .001
.2) 322 23.3 (3.1) .063 .457 .146 1.000
1.9) 315 29.8 (17.2) .005 1.000 .004 .036
43 12.7 .095 1.000 .159 .108
IA, common iliac arteries; SD, standard deviation.
fy differences between the groups. For discrete variables, post hoc analyses
g these groups. To correct for the 3 simultaneous comparisons, we applied
267 per variable.ascul
b
ean (
.3 (7
.1 (1
.7 (3
.5 (1
gists; C
identim, and a rupture occurred in 6 of these patients (5.2%).
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patients had a Vanguard stent graft. Vanguard stent grafts
had been used in 11 of the 26 patients (42.3%) in the
cohort with a ruptured AAA, and in 4 of the 9 patients
Fig 2. Rupture rate strati
Table II. Significant different variables between the
groups in demographic characteristics, aneurysm
anatomy, and type of stent were tested by univariate
analysis for risk of rupture
Variable HR (95% CI)
Age 1.035 (0.981-1.091)
Male sex 0.509 (0.153-1.698)
Hypercholesterolemia 1.366 (0.401-4.653)
Pre-op aneurysm diameter per mm 1.044 (1.026-1.062)
Infrarenal aortic neck length per mm 0.953 (0.913-0.994)
Aneurysmatic common iliac arteries 0.355 (0.029-4.284)
AAA expansion
8 mm 1.585 (0.456-5.518)
8 and 8 mm Reference
8 mm 6.008 (2.573-14.032)
AneuRxa 0.207 (0.028-1.529)
Excluderb 0.409 (0.055-3.207)
Talenta 0.718 (0.247-2.089)
Vanguardc 4.107 (1.848-9.126)
Zenithd 0.743 (0.297-1.861)
Procedure device-related complications 1.871 (0.253-13.824)
Stent migration 1.497 (0.352-6.372)
Kinking of the graft 2.286 (0.677-7.720)
AAA, Abdominal aortic aneurysm; CI, confidence interval; HR, hazard
ratio.
aMedtronic, Minneapolis, Minn.
bW. L. Gore and Associates, Flagstaff, Ariz.
cBoston Scientific Corp, Natick, Mass.
dCook Inc, Bloomington, Ind.(44.4%) in the expansion group with ruptured AAAs.How- aver, not all Vanguards (n 35) in group C led to rupture
n  4; 11.4%). The mortality rate from post-EVAR rup-
ure in the 26 patients was 62%.
There were 83 conversions to open AAA repair. Over-
y aneurysm enlargement.
able III. Independent risk factors for rupture of
neurysm, outcome of multivariable Cox analysis
ariable HR (95% CI)
re-op aneurysm diameter per mm 1.053 (1.032-1.074)
ength of infrarenal aortic neck per mm 0.951 (0.907-0.997)
AA expansion
8 mm 1.400 (0.400-4.901)
Between 8 and 8 mm Reference
8 mm 5.897 (2.490-13.967)
anguard stent grafta 4.524 (2.000-10.231)
AA, Abdominal aortic aneurysm; CI, confidence interval; HR, hazard
atio.
Boston Scientific Corp, Natick, Mass.
able IV. An overview of the different annual rupture
isks in group C
ear of FU
Combined FUa
(years)
Ruptures
(n)
Annual rupture
rate (%)
264 0 0
206 1 0.5
149 0 0
102 0 0
67 5 7.5
37 0 0
22 3 13.6
U, Follow-up.
Combined FU years were calculated for each interval.ll, the freedom from conversion at 7 years was 88.6%.
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December 20111618 Koole et alWhen we compared group C with groups A and B, the
freedom from conversion at 7 years in group C was 62%
compared with 97.5% in group A and 92.1% in group B
(P  .001, Fig 3). Univariate analysis (Table VI) allowed
selection of variables with significant differences, which
were subsequently entered in a multivariable Cox model.
This model indicated AAA enlargement without detectable
endoleaks was an independent factor for conversion (Table
VII). The mortality rate of conversion to open AAA repair
in patients without AAA rupture was 6.0%.
We also analyzed the risk of aneurysm-related death
stratified by aneurysm growth. In total, 162 patients died of
aneurysm-related causes. The freedom from aneurysm-
related death in the study cohort was 97.4%. In group C,
14.5% of aneurysm-related deaths occurred at 7 years,
compared with 1.2% in group A and 10.5% in group B (P 
.001). Multivariable analysis did not identify aneurysm
enlargement of8mm (group C) as an independent factor
for aneurysm-related deaths in this study cohort (P 
.173).
Excluder stent grafts (W. L. Gore and Associates, Flag-
staff, Ariz) were more often used in group C than in the
other groups (P  .001, Table VIII). This was the only
stent graft that was independently predictive for aneurysm
enlargement without detectable endoleaks in a multivari-
able analysis (95% confidence interval, 1.450-2.598; P 
.001). The EUROSTAR database registered 36 high-
permeability Excluder stent grafts in group C patients.
There was one low-permeability Excluder stent graft in the
EUROSTAR database. For 18 patients, it was not clear
whether they had a low- or high-permeability Excluder
stent graft, because these stents were implanted during the
transition era (2003 to 2005). Of the 55 patients with
Excluder stent grafts, 52 had no transfemoral intervention,
which means they did not receive a relining of their Ex-
cluder. Of the three patients who underwent a transfemoral
intervention, one had a thrombectomy, and two had a
relining.
DISCUSSION
In 2000 an international conference consisting of 27
Table V. Characteristics of patients with a ruptured
abdominal aortic aneurysm (AAA) in group C
Patient
AAA diameter at
last FU, mm Vanguard
1 50 Yes
2 54 Yes
3 49 Yes
4 83 No
5 91 Yes
6 106 No
7 88 No
8 70 No
9 77 No
FU, Follow-up.experts was organized about the nature and significance of sndoleaks and endotension,20 and introduced a modified
lassification scheme to permit a more detailed categoriza-
ion of endoleaks and endotension. This classification
cheme specified that a detected type I or type III endoleak
ad to be treated. Type II endoleaks are usually benign and
esolve spontaneously; however, not all type II endoleaks
re benign, and some require treatment.20 The classifica-
ion scheme also describes the possible different forms of
ndotension, including endotension without any endoleak,
ealed endoleak, or endoleaks that only become apparent
hen the aneurysm sac is opened at operation. An aggres-
ive treatment policy is currently recommended for aneu-
ysms without imaging-detected evidence of an endoleak
hat enlarge after EVAR.18,20
We analyzed the EUROSTAR database to investigate
he risk of rupture in patients without detectable endoleaks
n imaging studies. Aneurysm enlargement was defined as
diameter increase of 8 mm because of a presumably
arger interobserver variability in the large number of insti-
utions participating in the registry compared with a single-
nstitution assessment.7,24-26 To our knowledge, this is the
argest multicenter study to date evaluating the risk of
upture for this group.
Our analysis demonstrated aneurysm enlargement
ithout detectable endoleaks was an independent risk fac-
or for AAA rupture after EVAR. Furthermore, a large
reoperative AAA diameter, shorter infrarenal neck, and
he Vanguard stent graft were independent risk factors for
AA rupture. However, group C had more patients with
maller preoperative diameters and shorter infrarenal necks.
reason for smaller AAAs in group C might be the 8 mm
hreshold. Shrinkage of 8 mm occurs predominantly in
AAs with large preoperative diameters. If a large preoper-
tive AAA shrinks 15% in diameter, there is an increased
hance of reaching the 8 mm threshold compared with a
mall preoperative AAA.
Moreover, the multivariable analysis showed that pre-
perative AAA diameter and infrarenal neck length are not
he only risk factors or the strongest risk factors; for exam-
le, group C had an increased percentage of Vanguard
tent grafts, which were strongly associated with rupture.
he Excluder stent graft was more often used in group C.
his is an important factor for AAA expansion, and thereby
ould possibly increase rupture risk in this group, regardless
f the preoperative AAA diameter size. A large number of
igh-permeability Excluder stent grafts were implanted in
roup C, and 53 were not relined.
The calculated mean annual rupture risk in group C
ver 7 years was 1.1%. This rupture risk is comparable with
upture rates in general after EVAR in other cohorts, as
eported in literature.3,9-13,15,27 Furthermore, we observed
n annual rate of rupture in group C of 1% in the first 4
ears, which accelerated to 7.5% up to 13.6% in the years
hereafter. According to the SVS and ESVS guidelines, an
lective operation is indicated for patients with an AAA of at
east 5.5 cm. The rupture risk of these patients varies
etween 3% and 15%.18,19,28 The Vanguard stent graft is a
trong independent risk factor for rupture in this cohort.
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grafts is associated with fabric tears, stent fractures, and
disintegration of the stent graft, which can result in rup-
Fig 3. Conversion rate stra
Table VI. Significant different variables between the
groups in demographic characteristics, aneurysm
anatomy, and type of stent were tested by univariate
analysis
Variable HR (95% CI)
Age 0.957 (0.931-0.983)
Male gender 1.032 (0.418-2.549)
Hypercholesterolemia 0.853 (0.391-1.862)
Pre-op AAA diameter per mm 1.015 (0.999-1.031)
Length of infrarenal aortic neck per
mm 0.981 (0.961-1.001)
Aneurysmatic common iliac arteries 0.195 (0.027-1.408)
AAA expansion
8 mm 0.686 (0.275-1.716)
Between 8 and 8 mm Reference
8 mm 4.269 (2.624-6.946)
AneuRxa 0.567 (0.273-1.178)
Excluderb 0.373 (0.118-1.184)
Talenta 1.073 (0.636-1.813)
Vanguardc 2.917 (1.830-4.651)
Zenithd 0.090 (0.028-0.285)
Procedure device-related
complications
2.977 (1.204-7.358)
Stent migration 10.200 (6.447-16.139)
Kinking of the graft 2.784 (1.464-5.295)
Aortic stenosis or thrombosis 1.841 (0.920-3.686)
AAA, Abdominal aortic aneurysm; CI, confidence interval; HR, hazard
ratio
aMedtronic, Minneapolis, Minn.
bW. L. Gore and Assoc, Flagstaff, Ariz.
cBoston Scientific Corp, Natick, Mass.
dCook Inc, Bloomington, Ind.ture.11,29,30 sA Vanguard stent graft was used to treat 35 patients in
roup C, and the AAA ruptured in 4 patients (11.4%)
uring follow-up. Patients in group C treated with a Van-
uard stent graft ruptured at relatively small AAA diameters
f 70 mm. This is in contrast with the size of aneurysm
acs that were implanted with other stent grafts, which only
uptured at an AAA diameter of70 mm. In group C, the
nnual rupture risk was 1% in the first 4 years and is
robably minimal in patients without a Vanguard stent
raft and an AAA diameter 70 mm. It might be even
ower these days due to a better detection of endoleaks by
mproved imaging techniques.31,32 The mortality rate for
lective conversions in our cohort was 6.0%, which is con-
iderable. Hence, the need for conversion in patients pre-
by aneurysm enlargement.
able VII. Dependent and independent factors for
onversion and outcome of multivariable Cox analysis
ariable HR (95% CI)
ge 0.962 (0.935-0.990)
AA expansion
8 mm 0.767 (0.305-1.925)
Between 8 and 8 mm Reference
8 mm 3.635 (2.223-5.946)
anguarda 2.156 (1.332-3.490)
enithb 0.158 (0.049-0.509)
rocedure device-related complications 4.381 (1.745-10.996)
tent migration 7.420 (4.548-12.106)
inking of the graft 0.785 (0.389-1.585)
AA, Abdominal aortic aneurysm; CI, confidence interval; HR, hazard
atio.
Boston Scientific Corporation, Natick, Mass.
Cook Inc, Bloomington, Ind.enting with aneurysm enlargement without detectable
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December 20111620 Koole et alendoleaks, who are at a low risk for rupture, needs to be
reconsidered and set alongside a conservative policy.
This study observed an accelerated annual rupture risk
after the first 4 years. After 4 years, the cohorts were small
due to the long duration of follow-up, and therefore, the
issue of loss to follow-up bias merits careful consideration.
Patients with large aneurysms or fast-growing aneurysms
may tend to be more compliant with the scheduled follow-
up. This could explain the reduced rate of loss to follow-up
in group C. In addition, this study analyzed the risk of
rupture for patients with endoleaks combined with8 mm
shrinkage, 8 mm shrinkage to 8 mm expansion, and
8 mm expansion. Rupture occurred significantly more in
patients with endoleaks compared with patients without
endoleaks (group A: 1.5% vs 0.3%, P .001; group B: 5.1%
vs 0.4%, P  .001; and group C: 7.5% vs 2.6%, P  .012).
We observed a significantly higher conversion rate in
group C compared with groups A and B. Multivariable
analysis confirmed aneurysm enlargement without detect-
able endoleak as an independent factor for conversion.
Although excellent results were reported in some small
series of patients, most studies report conversion to open
AAA repair after EVAR with a comparable or higher mor-
tality rate than primary open AAA repair.14,27,33,34 This is
in agreement with a mortality rate of 6.0% in our study
when conversions in patients without rupture were consid-
ered. A higher preemptive conversion in group C may have
affected the annual rupture risk. To get an impression of the
possible influence of elective conversions on annual rupture
risk in group C, we assumed that the 26 conversions in
group C were ruptured on the day of conversion. We took
these ruptures into account and recalculated the annual
rupture rate. Nevertheless, even with this assumption, the
annual rupture risks are 2% in the first 3 years, and still
5% in the fourth year.
Management strategies for AAA enlargement without
Table VIII. Stent graft type distribution in groups A, B, a
Variable
Group Aa
No. (%)
Gr
N
AneuRxd 83 (12.0) 558
Excludere 52 (7.5) 622
Talentd 163 (23.6) 1325
Vanguardg 50 (7.2) 447
Zenithh 267 (38.6)i 1912
Other 76 (11.0) 443
Total 691 (100) 5307
Vanguard tendency of P  .091 more frequent use in group C than A. Tale
aAneurysm shrinkage 8 mm.
bAneurysm shrinkage 8 mm to enlargement 8 mm.
cAneurysm enlargement 8 mm.
dMedtronic, Minneapolis, Minn.
eW. L. Gore and Assoc, Flagstaff, Ariz.
fP  .001 resp P  .013 more frequent use in group C than A resp group B
gBoston Scientific Corp, Natick, Mass.
hCook Inc, Bloomington, Ind.
iP  .034 more frequent use in group A than C.detectable endoleaks are still evolving. Before treatment, tccurate imaging seems essential to rule out endoleaks.
ecause some endoleaks are not detectable with conven-
ional CT angiography, visualizing low-flow endoleaks
ith a blood-pool contrast agent, dynamic electrocardio-
raphically gated CT angiography, or MR angiography
ould possibly improve sensitivity for detecting en-
oleaks.31,32 This might possibly result in better endoleak
nd endotension stratification and decrease the mortality
isk from rupture in group C. Unfortunately, no specific
egistration concerning endoleaks detected at the time of
upture in the EUROSTAR database was available. There-
ore, it remains unclear whether there were endoleaks that
ere not being detected by imaging in ruptured patients of
roup C.
A variety of treatment options are presently available for
atients with AAA enlargement without an endoleak. Strat-
gies include conversion to open AAA repair, percutaneous
ranslumbar puncture of the aneurysm sac with aspiration
f the content, or conservative treatment.35,36 For most
atients, however, the mortality risk of a conversion seems
igher than the risk of rupture, and a percutaneous
ranslumbar puncture of the aneurysm sac also carries a
mall risk for complications.37 Considering the results and
eports above, we advise a conservative policy up to the first
years for patients at low-risk of rupture instead of conver-
ion to open AAA repair for those with aneurysm enlarge-
ent without imaging-detected endoleaks.
An exception is the first-generation Excluder stent
raft. This stent graft has been associated with graft poros-
ty.32 Endograft relining for the first-generation Excluder
nd reinforcements of the proximal and distal seal zones
ith cuffs and additional limbs seems a safe and reliable
lternative treatment option.17,38
A limitation of the study includes different imaging
odalities during the follow-up of some patients. How-
ver, most of the patients had the same types of imaging
b Group Cc
No. (%)
Total
No. (%)
5) 31 (9.1) 672 (10.6)
7) 55 (16.2)f 729 (11.5)
0) 70 (20.6) 1558 (24.6)
) 35 (10.3) 532 (8.4)
0) 108 (31.9) 2287 (36.1)
) 40 (11.8) 559 (8.8)
) 339 (100) 6337 (100)
dency of P  .074 more frequent in group B than C.nd C
oup B
o. (%)
(10.
(11.
(25.
(8.4
(36.
(8.3
(100
nt ten
.ests during follow-up, at the specific times in the study. CT
11
1
1
1
1
1
1
1
1
2
2
2
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Volume 54, Number 6 Koole et al 1621imaging was used in 85.3% at the times evaluated. More-
over, an increased threshold of 8 mm was set in the
EUROSTAR database to limit the influence of interob-
server variability.7,24-26 Therefore, it seems reasonable that
a possible influence of variation between different imaging
modalities in this study cohort is relatively limited.
Furthermore, there were no requirements concerning
the central lumen-line technique. This is also one of the
reasons why the threshold for expansion is as high as 8 mm.
With AAA diameter measurements only, it is possible to
miss AAA sac growth. AAA volumemeasurements aremore
sensitive for AAA growth than AAA diameter measure-
ments.39 Therefore, it would be desirable to perform vol-
ume measurements in addition to (orthogonal) diameter
measurements in future studies.
Also, a large number of patients were lost to follow-up.
After the 2-year interval, data for 50% of the patients in
group A and B were not available and30% of the patients
in group C were lost to follow-up. Loss to follow-up in
group C, which raised our interest, was significantly smaller
but still large. This aspect is inherent to a registry such as
EUROSTAR. Despite these limitations, a standard error
10% after 7 years in the survival table analysis is statisti-
cally adequate for a valid assessment.
CONCLUSIONS
The risk of rupture in patients with an AAA enlarge-
ment of 8 mm after EVAR without detectable endoleaks is
1% in the first 4 years. No ruptures were seen in patients
with AAA enlargement without detectable endoleaks, who
were not treated with Vanguard stent grafts and had AAA
diameters of 70 mm. For this group, conversion to open
repair might not be mandatory, and regular follow-up can
be advised instead. After 4 years of follow-up, this study
observed an increased annual rupture risk, which might
indicate the need for conversion; however, groups are
small, and follow-up bias could play a role.
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